First Patient Enrolled in Rise Therapeutics ' Rheumatoid Arthritis Clinical Trial

ROCKVILLE, Md., Jan. 29, 2024. Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has enrolled its first patient in its R-2487 Phase 1 rheumatoid arthritis clinical...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials